Skip to content

A comparative study of hyperventilation with and without end tidal carbon dioxide monitoring on seizure quality in patients with psychiatric disorders receiving electroconvulsive therapy

A comparative study of hyperventilation with and without end tidal carbon dioxide monitoring on seizure quality in patients with psychiatric disorders receiving electroconvulsive therapy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260714001
Enrollment
30
Registered
2026-07-14
Start date
2024-07-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric disorder requiring electroconvulsive therapy electroconvulsive therapy seizure quality hyperventilation end-tidal CO2

Interventions

Hyperventilation was administered via facemask at a rate of at least 20 insufflations per minute with EtCO2 monitoring, and the procedure continued until the EtCO2 target of 30 mmHg or less was reache
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Hyperventilation with EtCO2 monitoring (EtCO2 protocol),Conventional hyperventilation (Conventional protocol)

Sponsors

Faculty of Medicine, Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Diagnosis of major depressive disorder (MDD), bipolar disorder, schizophrenia, schizoaffective disorder, or treatment resistant dementia with BPSD 2) Indicated for receiving ECT at Siriraj Hospital 3) No change in ECT parameters and medications for at least 2 sessions of ECT prior to the study

Exclusion criteria

Exclusion criteria: 1) Severe or unstable cardiovascular disease e.g., recent myocardial infarction, unstable angina, poorly compensated congestive heart failure, severe valvular cardiac disease, or have an episode of these conditions within 1 month 2) Aneurysm or vascular malformation 3) Have signs of increase intracranial pressure or have brain tumor or space-occupying cerebral lesions 4) Recent cerebral infarction/hemorrhage within 1 month 5) Pulmonary condition e.g., COPD/asthma with acute exacerbation, pneumonia within 1 month 6) American Society of Anesthesiologists (ASA) class 4 or 5 7) Pregnancy

Design outcomes

Primary

MeasureTime frame
Seizure quality during intervention seizure duration and Glenside EEG Rating Scale for ECT (GERSE)

Secondary

MeasureTime frame
Side effects and adverse events Immediately after intervention Clinical assessment,Hemodynamic parameters before anesthetic induction, immediately after the ECT stimulus dose was delivered, and before participants were transferred to the recovery room Clinical assessment

Countries

Thailand

Contacts

Public ContactKantanut Yutritak

Mahidol University

kantanut.yut@mahidol.ac.th0241194293

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026